Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Open Angle Glaucoma Clinical Trials

10 recruiting trials for Open Angle Glaucoma. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
10
Total Trials
10
Recruiting Now
0
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT06313749

Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle...

The goal of this clinical trial is to show non-inferiority of the MIMS® device/procedure with Mitomycin-C, in terms of its surgical success rate, compared to trabeculectomy with...

Sponsor: Sanoculis LtdEnrolling: 1291 location
RECRUITINGPhase 4NCT07217678

Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use

The objective of this study is to evaluate whether reduction in topical medication with the injection of a sustained release capsule (Durysta) leads to a reduction in ocular...

Sponsor: University of MiamiEnrolling: 201 location
RECRUITINGPhase 4NCT07228221

Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma

The Investigators will investigate the efficacy of combining the standalone iStent infinite and iDose that are minimally invasive surgical and drug depot options are a safe and...

Sponsor: Jonathon MyersEnrolling: 201 location
RECRUITINGPhase 4NCT07325240

24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients

The purpose of this study is to evaluate the effect on 24-hour IOP reduction of netarsudil-latanoprost fixed combination in one eye compared to latanoprost alone in the...

Sponsor: Mayo ClinicEnrolling: 301 location
RECRUITINGPhase 4NCT05821855

A Study to Evaluate Adverse Events and Change in Disease Activity With the XEN45 Glaucoma Treatment System Implantation...

Glaucoma is the second most common cause of blindness in the world, second only to cataracts. The purpose of this study is to assess adverse events (AEs) and changes in disease...

Sponsor: AbbVieEnrolling: 13013 locations
RECRUITINGNCT06523751

Trabeculopuncture as Predictive Test for the Success of Ab Interno Trabeculectomy

The purpose of this study is to perform trabeculopuncture a test to determine the distal outflow tract function to predict the success of ab interno trabeculectomy.

Sponsor: Wuerzburg University HospitalEnrolling: 551 location
RECRUITINGNCT06953349

Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis

Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis

Sponsor: Barnet Dulaney Perkins Eye CentersEnrolling: 3001 location
RECRUITINGPhase 1NCT06267274

A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical...

A randomized, double-blind, parallel-group, two-arm, multiple dose, multicenter, clinical endpoint bioequivalence study

Sponsor: Amneal Pharmaceuticals, LLCEnrolling: 2404 locations
RECRUITINGNCT05269680

STAR-LIFE: a Post-market Registry on MINIject

As part of the post-market clinical follow-up (PMCF), this registry is developed to ensure real-world data collection on MINIject device.

Sponsor: iSTAR MedicalEnrolling: 7501 location
RECRUITINGNCT06246136

Comparative Effectiveness and Safety of ELIOS in Patients With Open-Angle Glaucoma Undergoing Cataract Surgery

The primary study objective is to compare the effectiveness of the combination of phacoemulsification with intraocular lens implant with ELIOS or competitor device in reducing IOP...

Sponsor: Elios Vision, Inc.Enrolling: 19416 locations